Melatonin as a Potential Treatment for SARS-CoV-2

Joseph Mercola

More than 140 scientific studies suggest melatonin is a useful agent for treating SARS- CoV-2, according to research published in Cellular and Molecular Life Sciences.

Melatonin was most often researched for its ability to suppress inflammation and the cytokine storm related to COVID-19.

When people with COVID-19 were given melatonin, either alone or in combination with other treatments, severity of infection was reduced, death rate was lowered and hospitalizations were shortened.

Early on during the pandemic, a number of physicians and researchers called for melatonin in the treatment of COVID-19, but it was largely ignored.

Since melatonin is nonpatentable and inexpensive, there was little interest from the pharmaceutical industry or their government counterparts in promoting this compound.

Latest articles

Salle de presse Scientists at the CRCHUM find that a bacterium called...
Robin Monotti I think for three years there’s been a fight over...
William S. Bathgate Building Biology Environmental Consultant William S. Bathgate discusses the...
Lloyd Burrell Electricity was originally introduced to the mass population in the...
Mudan Cai and Eun Jin Yang Background: Amyotrophic lateral sclerosis (ALS) is a...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!